-
August 23: The Week in Cancer News
Early immunotherapy may make more liver cancer patients eligible for surgery, and the FDA approves a new use for a lung cancer treatment.
by Kevin McLaughlin
-
August 16: The Week in Cancer News
Even small amounts of alcohol can increase cancer mortality risk, and research explores the role of weight-loss drugs in preventing cancer.
by Marci A. Landsmann
-
Sensorimotor Training Helps Prevent Chemotherapy-induced Peripheral Neuropathy
The specialized balance training exercise can help keep the nervous system healthy during chemotherapy by giving it a workout.
by Sandra Gordon
-
August 9: The Week in Cancer News
More endometrial cancer patients can now receive an immunotherapy, and taking aspirin regularly may help some people reduce their risk for colorectal cancer.
by Thomas Celona
-
August 2: The Week in Cancer News
Blood test approval widens access to colorectal cancer screening option, and language barriers interrupt cancer care before it starts.
by Eric Fitzsimmons
-
What Is Liquid Biopsy?
Blood tests, often called liquid biopsy, could be key to early cancer detection and monitoring response to treatment.
by Cancer Research Catalyst
-
July 26: The Week in Cancer News
Double mastectomy doesn’t lead to a survival advantage over lumpectomy or single mastectomy, and research explores hearing loss linked to cisplatin.
by Marci A. Landsmann
-
Living With Your Loved One’s Prostate Cancer
Christine Ledbetter on the ways her husband’s prostate cancer affected their relationship and finding support as a caregiver.
by Christine Ledbetter
-
July 19: The Week in Cancer News
Education about mammography is linked to reduced screening for women in their 40s, and pancreatic cancer discovery could lead to new treatments.
by Kevin McLaughlin
-
Continuing the Conversation
The AACR hosts a roundtable to ‘get real’ about cancer health disparities.
by Marci A. Landsmann
Cancer Talk
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live Longer
Findings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff
Cancer Today Editors’ Picks: 2024Our favorite Cancer Today stories from 2024, as picked by the editors.